Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

[HTML][HTML] 2019 European Thyroid Association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer

L Fugazzola, R Elisei, D Fuhrer, B Jarzab… - European thyroid …, 2019 - etj.bioscientifica.com
The vast majority of thyroid cancers of follicular origin (TC) have a very favourable outcome,
but 5–10% of cases will develop metastatic disease. Around 60–70% of this subset, hence …

Pathogenesis of cancers derived from thyroid follicular cells

JA Fagin, GP Krishnamoorthy, I Landa - Nature reviews Cancer, 2023 - nature.com
The genomic simplicity of differentiated cancers derived from thyroid follicular cells offers
unique insights into how oncogenic drivers impact tumour phenotype. Essentially, the main …

[HTML][HTML] DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma

IA González, DR Stewart, KAP Schultz, AP Field… - Modern Pathology, 2022 - Elsevier
Abstract DICER1 syndrome (OMIM 606241, 601200) is a rare autosomal dominant familial
tumor predisposition disorder with a heterozygous DICER1 germline mutation. The most …

[HTML][HTML] Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer

SK Yoo, YS Song, EK Lee, J Hwang, HH Kim… - Nature …, 2019 - nature.com
Anaplastic thyroid cancer (ATC) and advanced differentiated thyroid cancers (DTCs) show
fatal outcomes, unlike DTCs. Here, we demonstrate mutational landscape of 27 ATCs and …

Poorly differentiated carcinoma of the thyroid gland: current status and future prospects

T Ibrahimpasic, R Ghossein, JP Shah, I Ganly - Thyroid, 2019 - liebertpub.com
Background: Poorly differentiated thyroid cancer (PDTC) is a rare but clinically highly
significant entity because it accounts for most fatalities from non-anaplastic follicular cell …

[HTML][HTML] The 5th edition of WHO classification of tumors of endocrine organs: changes in the diagnosis of follicular-derived thyroid carcinoma

F Basolo, E Macerola, AM Poma, L Torregrossa - Endocrine, 2023 - Springer
The 5th edition of the World Health Organization (WHO) classification of endocrine tumors
was released in 2022. Several novelties have been introduced concerning the …

The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and …

Y Ito, N Onoda, T Okamoto - Endocrine journal, 2020 - jstage.jst.go.jp
Abstract The Japan Associations of Endocrine Surgeons has developed the revised version
of the Clinical Practice Guidelines for Thyroid Tumors. This article describes the guidelines …

[HTML][HTML] Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations

RD Chernock, B Rivera, N Borrelli, DA Hill… - Modern Pathology, 2020 - Elsevier
Poorly differentiated thyroid carcinomas (PDTC) in young individuals are rare and their
clinical and histopathologic features, genetic mechanisms, and outcomes remain largely …

[HTML][HTML] Thyroid carcinoma: phenotypic features, underlying biology and potential relevance for targeting therapy

J Hu, IJ Yuan, S Mirshahidi, A Simental, SC Lee… - International journal of …, 2021 - mdpi.com
Thyroid carcinoma consists a group of phenotypically heterogeneous cancers. Recent
advances in biological technologies have been advancing the delineation of genetic …